bromobenzenes - CISMeF

Preferred Label : bromobenzenes;

MeSH definition : Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.;

Wikipedia automatic translation : Bromobenzene;

Wikipedia link : https://en.wikipedia.org/wiki/Bromobenzene;

Is substance : O;

Détails

Origin ID

D001969;

UMLS CUI

C0006228;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Bromobenzene (substance) [SNOMED CT concept]
- bromobenzene [Substance BNPC]
Record concept(s)
- bromobenzenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- (4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo(d)imidazol-1-yl)acetic acid [MeSH Supplementary Concept]
- 1,2,4,5-tetrabromobenzene [MeSH Supplementary Concept]
- 1,2,4-tribromobenzene [MeSH Supplementary Concept]
- 1,2-bis(2,4,6-tribromophenoxy)ethane [MeSH Supplementary Concept]
- 1,2-dibromobenzene [MeSH Supplementary Concept]
- 1,3-dibromobenzene [MeSH Supplementary Concept]
- 1,4-dibromobenzene [MeSH Supplementary Concept]
- 1,5-bis(2-bromophenyl)penta-1,4-dien-3-one [MeSH Supplementary Concept]
- 1-bromo-4-tert-butylbenzene [MeSH Supplementary Concept]
- 15-(4-bromophenyl)pentadecanoic acid [MeSH Supplementary Concept]
- 2,6-dibromo-4-cyanophenoxyacetic acid [MeSH Supplementary Concept]
- 3-(4-bromophenyl)propionic acid [MeSH Supplementary Concept]
- 3-bromo-3,5-cyclohexadiene-1,2-diol [MeSH Supplementary Concept]
- 3-bromobenzylguanidine [MeSH Supplementary Concept]
- 4-bromobenzenesulfonamide [MeSH Supplementary Concept]
- CX-F9 [MeSH Supplementary Concept]
- DCAC50 [MeSH Supplementary Concept]
- MST-04 compound [MeSH Supplementary Concept]
- N-(2-chloro-4-nitrophenyl)-2-acetoxy-3,5-dibromobenzamide [MeSH Supplementary Concept]
- R 8231 [MeSH Supplementary Concept]
- bromfenac [MeSH Supplementary Concept]
- bromobenzene [MeSH Supplementary Concept]
- bromobenzene 2,3-oxide [MeSH Supplementary Concept]
- bromobenzene 3,4-oxide [MeSH Supplementary Concept]
- ceratinamine [MeSH Supplementary Concept]
- cincreasin [MeSH Supplementary Concept]
- decabromodiphenyl ethane [MeSH Supplementary Concept]
- filiformin [MeSH Supplementary Concept]
- hexabromobenzene [MeSH Supplementary Concept]
- pulmonarin A [MeSH Supplementary Concept]
- pulmonarin B [MeSH Supplementary Concept]
- purealidin N [MeSH Supplementary Concept]
- purealidin S [MeSH Supplementary Concept]
- purealin [MeSH Supplementary Concept]
- purpuramine J [MeSH Supplementary Concept]
- subereaphenol C [MeSH Supplementary Concept]
- tetrabromobisphenol-S-bis(2,3-dibromopropyl ether) [MeSH Supplementary Concept]
- tetradecabromodiphenoxybenzene [MeSH Supplementary Concept]
- vidalol A [MeSH Supplementary Concept]
- vidalol B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients